The Drug Enforcement Administration (DEA) has finally announced, after nearly 4 years, that 37 applications to grow cannabis for medical research, will be evaluated, while proposing new rules for the prospective growers, thus outlining how the cannabis-growing program would work.
According to one of the applicants, CEO of the Biopharmaceutical Research Company, George Hodgin, this framework’s release is probably the biggest, the most meaningful, and material progress that has been made for decades, in the federal cannabis policy. He further adds that this will further open a path for the traditional drug development in the United States, while researchers can conduct trials and seek approval for marijuana-based therapies, from the Food and Drug Administration (FDA).
However, everyone didn’t share the optimism of Hodgin. According to Shane Pennington, an attorney at Yetter Coleman LLP – a Houston law firm representing one of the applicants, the Scottsdale Research Institute, it may take years for Federal rulemaking due to the involvement of soliciting and responding to public comments, especially potential litigation over the decision.
Currently, only the University of Mississippi has grown cannabis, which can be legally used for research in the United States, under a contract with the National Institute on Drug Abuse (NIDA). However, there has been growing interest in the potential medical benefits of cannabis, along with the increasing number of Americans using cannabis in states where the drug is legalized. Consequently, researchers are frustrated due to the limitation of the single source.
DEA announced the consideration of applications in August 2016, from other growers. Universities, research institutes, biotech startups, and companies that produced cannabis in states where it was legalized, were all included in the list of prospective growers. However, a few months later, the election of President Donald Trump followed, and a longtime marijuana critic, Jeff Sessions was appointed as attorney general, putting him indirectly in charge of DEA. According to Hodgin, the applicants waited for 3 years, with multiple attempts involved, at outreach through Congress and directly.
The delays frustrating SRI, caused a lawsuit against DEA to be filed in June 2019, aiming to compel it to evaluate and respond to the applications. Only after proposing rules for administering the whole program, was DEA ready to evaluate the pending applications. Reactions from applicants were mixed, ranging from cautiously optimistic to interpreting the move as a stall tactic.
DEA finally released the proposed rules last week. The agency noted that 595 researchers were registered to conduct cannabis studies – increasing from 371 researchers in 2017 and that the production quota for cannabis was increased from 472 to 3200 kilograms during the same time period.
According to Sisley and her legal time, the stipulation is seen as an unnecessary roadblock. She further added, asking why cannabis should be any different when DEA has a mechanism for allowing manufacture and distribution of other tightly regulated drugs for clinical research, that include MDMA, LSD, and psilocybin – all of which are studied as possible treatments for medical conditions such as PTSD and depression.
The new rules may require that growers should have broken no federal laws. If enforced, this may immediately eliminate several applicants and companies that already continue the production or distribution of cannabis in states where the drug is legalized, as growing and selling, or even the possession of cannabis is still a violation of federal law even in cannabis-legalized states.
According to Sisley, SRI complies with federal law and has not yet grown any cannabis, although the requirement will eliminate experienced growers who are responsible for the production of high-quality cannabis (who are essentially ideal participants)
Other countries including Canada and Australia, have licensed growers for research cannabis that are not legalized to take possession of the drug.
New York passes a bill to legalize Marijuana
Main Aim behind the Legalization
Will Marijuana become legal?
About Marijuana Movement
Good news for Sciatica patients: CBD oil relieves the pain
The recent studies on CBD oil have unfolded its utility in various fields of medicine. Researches on the effects of CBD oil on sciatica patients show that they can prove to be very useful in its treatment. The results have shown that the oil can work wonders to alleviate the Sciatica pain.
What is Sciatica?
Sciatica is a severe pain caused by disruption in the sciatica nerve. Anything that disturbs the nerve results in extreme and sometimes, unbearable pain.
Sciatica is a nerve that starts at the lower back and extends through the hips and legs to the toes. It sends messages from the brain to the legs via spinal cord. Since, it is a long nerve, patients usually complain of the pain at the lower back, hips, legs and heels.
A compression on the Sciatica causes this severe pain. The major causes of compression are a herniated disk, bone spur on the spine or narrowing of the spine.
What is CBD oil
CBD (Cannabidiol) is a chemical compound that is derived from the Marijuana plant. It relieves the pain without causing any psychoactive or mind-altering effects. CBD oil is made by extracting CBD powder from the marijuana plant. Coconut or olive oil is mixed in it for better application.
The recent researches on CBD oil have revealed its anti-seizure, neuroprotective and pain relieving properties. Due to its wondrous effects on human body, many celebrities advocate for CBD.
Utility of CBD oil for Sciatica patients
CBD oil works by increasing the number of pain modulators that stimulate a response to the pain. Our mind has cannabinoid receptors that modulate the pathways that stimulate a response to the pain and negative emotions.
As sciatica pain arises, the CBD oil applied on the respective part works to reach the brain in order to stimulate a faster response to the pain.
While the Sciatica is a very painful condition, it is mostly treatable with medicines. However, most pain relievers have side effects that cause harm in the long run. In contrast, CBD oil works naturally to enhance the receptors with minimum side effects.
Best CBD oil to relieve Sciatica
Every person’s reaction to different types of CBD oil varies from the other. One cannot say with surety, since what works for some might not work for the others. This is primarily because every person has a different set of genetics, general health and tolerance.
Natural and organic remedies take time to show their reaction. While CBD takes some time to relieve the pain, it is undoubtedly one of the harmless ways to do so.
CBD oil works best when used with the consultation of a doctor. Before buying, one should make sure that the oil contains laboratory verified ingredients.
Who owns the Suspicious Marijuana Farm Near Middleton Home?
The Police discovered a Marijuana Farm near Kate Middleton’s family home in Buckleberry in Berkshire. A power outage led to the discovery of the illegal farming of marijuana right next to Middleton’s 18 acrea estate, on Thursday.
The Middleton Estate
Kate Middleton’s parents, Carole and Michael Middleton, own a £4.7 million Grade II Manor house in Buckleberry in Berkshire. The purchased this property back in 2012 after moving from their £1.5 million house in the same village of Berkshire. The 18-acre estate consists of 7 bedrooms and 5 reception rooms. Carole and Michael moved here due to the better privacy and security this house offered.
The Middleton Family House holds great importance for the Duke and Duchess of Cambridge. The Duke and Duchess have spent a lot of fun moments at ‘The Manor’. All the sweet memories make The Manor a strong fort to hold.
Discovery of the Marijuana Farm
Upon calling, people from the electricity board came to solve the electricity power situation. The workers from the electricity board discovered the Marijuana Farm on the Wednesday night. They immediately brought this to the attention of the police. The police raided the area on Thursday and found an empty Cannabis factory.
A witness reported that about 6 vans collected the content inside the potential cannabis factory. The police has taken all the evidence for further investigation. The Police is investigating this case under the top priority badge. They have found some evidence that the empty and abandoned factory was previously being used as a safe space to make drugs from cannabis.
Until now, no arrests have been made and people are clueless about the owner of the factory. The police has asked the public to contact police if they have any information regarding the suspicious factory hidden in the barns. The investigating officer told the media that they are still carrying out an investigation. They are confident that they will soon get to the bottom of this matter.
As suspicious as it might sound, there is no confirmation to it. Kate Middleton is the Queen of Grace and her family is an epitome of class. The rumors about the Cannabis Factory being owned by the Middletons are circulating however, it seems nothing but a rumor. Royal family has always been subjected to such fake news every now and then. Previously rumors about Kate’s fourth pregnancy were also in the air and Kate having marital issues with Prince William also surfaced.
While the Police and CID are working hand in hand to solve the mystery of the Cannabis factory and marijuana farm right next to the Middleton Family House, people are looking forward to get their hands on the latest gossip.
- Cannabis1 year ago
How CBD oil works?
- Cannabis11 months ago
CBD Gummies: How does it work? Benefits, Pricing and Packages
- Health6 months ago
Diabetes Freedom Review – A Natural Way To Beat Diabetes Type 2
- Cannabis1 year ago
Research Suggests Cannabis Effective in Treating Endometriosis
- Featured9 months ago
Prosper Wellness TurmeriCBD Review – A combination of Turmeric and CBD?
- Cannabis12 months ago
What are the main advantages of consuming CBD oil?
- Health7 months ago
VitaMove, a Popular Formula to Relieve Back Pain is Restocked
- Cannabis8 months ago
Can Cannabis Survive in Pharma?